Detalhe da pesquisa
1.
Structural Framework for Analysis of CD4+ T-Cell Epitope Dominance in Viral Fusion Proteins.
Biochemistry
; 62(17): 2517-2529, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37554055
2.
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.
Ann Rheum Dis
; 82(2): 292-300, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109141
3.
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
J Autoimmun
; 140: 103118, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37826919
4.
Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID-19 pandemic.
J Med Virol
; 95(6): e28830, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37282809
5.
Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick-borne encephalitis and dengue virus infections.
J Med Virol
; 95(11): e29245, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009693
6.
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients.
Ann Neurol
; 91(3): 342-352, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35067959
7.
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.
Ann Rheum Dis
; 81(5): 687-694, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027397
8.
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.
Ann Rheum Dis
; 81(12): 1750-1756, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977809
9.
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
J Clin Microbiol
; 59(5)2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602698
10.
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
Ann Rheum Dis
; 80(10): 1345-1350, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285048
11.
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19.
Genet Med
; 23(5): 963-967, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500568
12.
Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs.
Infection
; 49(1): 171-175, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785885
13.
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.
J Infect Dis
; 222(3): 362-366, 2020 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473021
14.
Increase in human West Nile and Usutu virus infections, Austria, 2018.
Euro Surveill
; 23(43)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376913
15.
The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
J Infect Dis
; 215(2): 214-220, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789725
16.
ACE2 Elevation in Severe COVID-19.
Am J Respir Crit Care Med
; 203(9): 1191-1196, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33600742
17.
Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.
J Virol
; 88(23): 13845-57, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25253341
18.
Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.
J Virol
; 88(14): 7828-42, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24789782
19.
Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna, Austria.
Eur J Pediatr
; 174(12): 1639-47, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109012
20.
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray.
Vaccines (Basel)
; 12(1)2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250907